NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)
CUSIP: 44975P103
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
- Shares outstanding
- 265,214,861
- Total 13F shares
- 9,526,320
- Share change
- +5,031,315
- Total reported value
- $447,661,000
- Price per share
- $47.03
- Number of holders
- 48
- Value change
- +$236,962,427
- Number of buys
- 36
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 44975P103:
Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.42%
|
1,117,317
|
$33,441,000 | — | 30 Jun 2020 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.3%
|
804,560
|
$23,067,000 | — | 30 Jun 2020 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.19%
|
494,161
|
$14,805,000 | — | 30 Jun 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.12%
|
324,000
|
$9,697,000 | — | 30 Jun 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
175,129
|
$5,242,000 | — | 30 Jun 2020 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.04%
|
118,409
|
$3,544,000 | — | 30 Jun 2020 | |
| FMR LLC |
13F
|
Company |
0.02%
|
52,525
|
$1,574,000 | — | 30 Jun 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.01%
|
34,966
|
$1,048,000 | — | 30 Jun 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
0.01%
|
32,624
|
$977,000 | — | 30 Jun 2020 | |
| NORGES BANK |
13F
|
Company |
0.01%
|
30,000
|
$899,000 | — | 30 Jun 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.01%
|
23,500
|
$703,000 | — | 30 Jun 2020 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.01%
|
19,910
|
$596,000 | — | 30 Jun 2020 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.01%
|
19,421
|
$582,000 | — | 30 Jun 2020 | |
| Vident Investment Advisory, LLC |
13F
|
Company |
0.01%
|
15,516
|
$464,000 | — | 30 Jun 2020 | |
| ETF MANAGERS GROUP, LLC |
13F
|
Company |
0.01%
|
15,975
|
$458,000 | — | 30 Jun 2020 | |
| NEW SILK ROAD INVESTMENT PTE LTD |
13F
|
Company |
0%
|
12,000
|
$359,000 | — | 30 Jun 2020 | |
| Invesco Ltd. |
13F
|
Company |
0%
|
7,178
|
$215,000 | — | 30 Jun 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,630
|
$49,000 | — | 30 Jun 2020 | |
| Snow Lake Capital (HK) Ltd |
13F
|
Company |
0.52%
|
1,385,975
|
$41,482 | — | 30 Jun 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
147
|
$4,000 | — | 30 Jun 2020 |
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q3 2020
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.